Nalaganje...
Mixed Response to Ipilimumab in a Melanoma Patient with Brain Metastases: Case Report and Review of the Literature
Management of patients suffering from metastatic malignant melanoma and brain metastasis remains challenging in routine clinical practice. The inhibitory anti-CTLA-4 antibody ipilimumab has recently been approved as second-line therapeutic option for melanoma patients. Increasing evidence suggests d...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3656679/ https://ncbi.nlm.nih.gov/pubmed/23687494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000351125 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|